News
Important Only
South African rand weakens as manufacturing beat fails to offset tariff nerves
JOHANNESBURG, Aug 11 (Reuters) - The South African rand was weaker on Monday as better-than-expected domestic manufacturing data failed to offset trade concerns, with the country scrambling to secure a lower tariff rate on its exports to the United States.U.S. imports from South Africa face a 30% du...Reuters
Mon, Aug 11
COLUMN-Which data point may shine light through US jobs fog?: McGeever
By Jamie McGeeverORLANDO, Florida, Aug 11 (Reuters) - Amid a blizzard of contradictory signals, it's becoming increasingly difficult to get any visibility on the U.S. labor market. But of all the numbers that feed into the all-important unemployment rate, the one worth paying most attention to m...Reuters
Mon, Aug 11
LIVE MARKETS-Benchmark Treasury yield coiling ahead of CPI
US equity index futures slightly greenEuro STOXX 600 index ~flatDollar, crude gain; bitcoin rallies >4%; gold down >1%US 10-Year Treasury yield edges down to ~4.27%Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at ...Reuters
Mon, Aug 11
4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Inc FDMT.OQ reported a quarterly adjusted loss of 98 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -63 cents. The mean expectation of eleven analysts for the quarter was for a loss of 88 cents per s...Reuters
Mon, Aug 11
Cadrenal Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Cadrenal Therapeutics Inc CVKD.OQ reported a quarterly adjusted loss of $1.87 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-2.25. The mean expectation of three analysts for the quarter was for a loss of $1.60 per share. Wall St...Reuters
Mon, Aug 11
4 of the Most Undervalued Stocks in the Market Right Now
In today's video, I will look at four stocks that have seen meaningful pullbacks and now appear undervalued. In a stock market that has largely been viewed as overvalued, not all stocks are participating in the big rebound off the April lows.One of the stocks I will discuss today is Novo Nordisk (NY...The Motley Fool
Mon, Aug 11
CNS Pharmaceuticals Inc expected to post a loss of $9.60 a share - Earnings Preview
CNS Pharmaceuticals Inc CNSP.OQ CNSP.O is expected to report resultson August 12 (estimated) for the period ending June 30 2025LSEG's mean analyst estimate for CNS Pharmaceuticals Inc is for a loss of $9.60 per share. The current average analyst rating on the shares is "buy" and the br...Reuters
Mon, Aug 11
Sonida Revenue Jumps 33 Percent in Q2
Key PointsGAAP loss per share narrowed to $(0.16) due to a one-time employee retention credit.Total revenue (GAAP) jumped 33.2% year over year to $93.5 million, compared to $70.2 million in Q2 2024, helped by acquisitions and occupancy gains.Same-store community net operating income margin (non-GAAP...The Motley Fool
Mon, Aug 11
BitMine Scoops Up Over 300,000 ETH in One Week — Stock Soars 10% in Pre-Market Trading
BitMine is now the third-largest crypto treasury globally, trailing only MicroStrategy and MARA Blockchain, and ranks as the 25th most liquid U.S. stock, trading an average of $2.2 billion per day.
TradingKey
Mon, Aug 11
Skydance-owned Paramount rises on $7.7 bln US rights deal with UFC
** Shares of Skydance-owned Paramount PSKY.O rise 3.7% to $10.9 in premarket trading ** Starting in 2026, PSKY will become the exclusive U.S. home of Ultimate Fighting Championship under a seven-year rights deal, valued at around $7.7 billion ** Company will exclusively distribute UFC's full sla...Reuters
Mon, Aug 11
SBC Medical Group Holdings Inc expected to post earnings of 14 cents a share - Earnings Preview
SBC Medical Group Holdings Inc SBC.OQ SBC.O is expected to report resultson August 13 for the period ending June 30 2025The Irvine California-based company is expected to report revenue of $44.712 million, according to the mean estimate from 2 analysts, based on LSEG data.LSEG's mean analyst ...Reuters
Mon, Aug 11
IO Biotech jumps after cancer vaccine shows promise in late-stage study
** Shares of biotech firm IO Biotech IOBT.O rise 59.7% to $2.89 premarket** Company says patients on its experimental cancer vaccine, in combination with Merck's MRK.N Keytruda, showed improvement in a late-stage study goal, but the result was not statistically significant** In a 407-patient, la...Reuters
Mon, Aug 11
SoFi Just Posted Earnings. Here's What Stood Out
Key PointsSoFi's second-quarter results showed better-than-expected growth and profitability. The progress with the loan platform has been an especially big profit driver.Student loans and home loans could become far more important to SoFi in the years to come. 10 stocks we like better than SoFi Tec...The Motley Fool
Mon, Aug 11
GLOBAL MARKETS-Stock and bond markets cautious ahead of big week for geopolitics and economic data
US futures slightly higher, world index near record topDollar, bonds await US CPI report to refine rate cut chancesOil steadies ahead of Trump/Putin meeting on Ukraine Gold down around 1%, traders grapple with tariff uncertainty By Wayne Cole and Alun John SYDNEY/LONDON, Aug 11 (Reuters) - Stocks...Reuters
Mon, Aug 11
Protara Beats Q2 Loss Estimates
Key PointsGAAP loss per share of $0.35 in Q2 2025 beat analyst expectationsResearch and development expenses rose 68.8% year-over-year in Q2 2025, reflecting ongoing clinical trial spending, while revenue remained at zero.Protara ended the quarter with $145.6 million in cash, cash equivalents, and i...The Motley Fool
Mon, Aug 11
J.P.Morgan cuts PT for EOG Resources on lower oil and gas price assumptions
** J.P.Morgan cuts PT for oil and gas producer EOG Resources EOG.N to $132 from $142** New PT represents an upside of 13.5% to the stock's last close** PT cut was due to decline in commodity price assumptions, brokerage says** Says EOG continues to execute well, with new drilling and appraisal o...Reuters
Mon, Aug 11
Aptevo Reports 85% Remission in Q2
Key PointsGAAP earnings per share for Q2 2025 was $8.40, far surpassing the consensus estimate of a loss of $83.20 per share.Mipletamig, the company’s lead bispecific antibody for acute myeloid leukemia, achieved an 85% remission rate (11 of 13 patients) across two trials in Q2 2025.Cash and equival...The Motley Fool
Mon, Aug 11
Micron Technology raises quarterly results forecast on AI-driven demand
Aug 11 (Reuters) - Micron Technology MU.O on Monday raised its forecast for fourth-quarter revenue and adjusted profit, due to surging demand for its memory chips used in artificial intelligence infrastructure, sending its shares up 5% before the bell.The company now expects revenue of $11.2 billion...Reuters
Mon, Aug 11
4dMT Revenue Jumps 200 Percent in Q2
Key PointsRevenue (GAAP) was $15.0 million in Q2 2025, outpacing analyst estimates by a wide margin and Revenue for the period surged to $15.0 million, tripling from Q2 2024.Research and development expenses (GAAP) grew 50.5% compared to Q2 2024, reflecting increased investment in late-stage clinica...The Motley Fool
Mon, Aug 11
This Dark-Horse AI Stock Has Great News for Investors
Key PointsAppian easily beat estimates on the top and bottom lines in Q2.Its new AI platform is accelerating the business.It's also making significant margin improvements thanks to go-to-market efficiencies.10 stocks we like better than Appian › Appian (NASDAQ: APPN) has long been a leader in low-co...The Motley Fool
Mon, Aug 11
